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In attempts to determine the mechanism of proliferation of arterial smooth muscle cells (SMC) in intimal atheromatous 
lesions, autocrine secretion of growth factors by SMC has recently received much attention. Here we report a new growth 
factor named smooth muscle cell derived growth factor (SDGF). Cultured rabbit medial SMC secreted SDGF for 1 week 
during their incubation in serum-free media only after at least 4 passages. SDGF differed from platelet derived growth 
factor (PDGF) physicochemically, immunologically, and biologically. The properties of SDGF also seemed different 
from those of other known growth factors that stimulate the proliferation of mesenchymal cells, 
Atherosclerosis; Growth factor; PDGF; Autocrine secretion; (Smooth muscle cell) 
1. INTRODUCTION 
Proliferation of smooth muscle cells @MC) in 
the arterial intima is a key event in the 
pathogenesis of atherosclerosis [l-3]. Some 
mitogen(s) are essential for the proliferation of 
SMC. Paracrine secretion of peptide growth fac- 
tors from platelets (platelet derived growth factor, 
PDGF) and macrophages or endothelial cells have 
been reported [l-3], and more recently autocrine 
secretion of a PDGF-like growth factor by aortic 
SMC has been demonstrated only in rats [4-81. 
We were interested in whether there is an 
autocrine system in species uch as rabbits that are 
much more susceptible to atherosclerosis than rats. 
In previous studies we could not detect any 
mitogenic activity in cultured rabbit aortic medial 
SMC at the 2nd or 3rd passage. However, we 
report here that at later passages SMC secreted a 
mitogenic factor that stimulated their own growth 
and was distinct from PDGF. 
Correspondence address: N. Morisaki, The Second Department 
of Internal Medicine, School of Medicine, Chiba University, 
1-8-1 Inohana, Chiba City 280, Japan 
2. MATERIALS AND METHODS 
2.1. Materials 
Polyclonal antiPDGF antibody and purified PDGF (purity > 
95%) were purchased from Collaborative Research Inc. (Lex- 
ington, MA) and R & D System Inc. (Minneapolis, MN), 
respectively. 
2.2. Collection of conditioned medium (CM) 
SMC from rabbit thoracic aortas were cultured as reported 
[9]. Confluent SMC in T-75 flasks at the 2nd passages were fur- 
ther subcultured by 1:2 split in T-75 flasks. CM was collected 
as follows. Confluent SMC in T-75 flasks at a certain passage 
were washed with 10 ml of Dulbecco’s modified Eagle’s 
medium (DME) twice and incubated with 10 ml of fresh DME. 
CM was collected every 2 days with change to 10 ml of fresh 
DME. 
2.3. DNA synthesis 
Confluent SMC at the 2nd or 3rd passage in 24-well plates 
(18 mm x 20 mm) were incubated with 1 ml of DME for 24 h, 
the medium was changed to 1 ml of CM (DME only for the con- 
trol) containing 1 pCi [‘Hlthymidine and the cells were in- 
cubated for 24 h. The radioactivity of the trichloroacetic 
acid-insoluble fraction was counted. 
2.4. Cell proliferation 
SMC at passage 2 were seeded onto 24-well plates 
(10OOO/well) with 1 ml of DME containing 10% fetal bovine 
serum and were incubated for 24 h to allow the cells to become 
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attached to the wells. Then the cells were washed twice with 
1 ml of DME and incubated with DME containing various con-. 
centrations of CM for indicated period. Cell numbers wert 
counted in a Coulter counter. 
The labeling of PDGF with “‘1 and lz51-PDGF binding to 
confluent fibroblast was done as described in [lo]. 
3. RESULTS AND DISCUSSION 
Significant mitogenic activity (defined as more 
than 3 times the control value) was first secreted in- 
to conditioned medium at the 4th to 10th passage 
depending on the primary culture, as shown in 
fig. 1A. One primary culture did not secrete signifi- 
cant amounts of mitogenic activity within 11 
passages. 
Fig. 1B shows typical time courses of secretion of 
mitogenic activity by confluent SMC from three 
different primary cultures from passage 4 to 6. 
SMC secreted the activity -1 week after the begin- 
ning of conditioning (fig.lB). 
Pooled conditioned media showed dose- 
dependent stimulation of DNA synthesis 
([3H]thymidine uptake) (fig.2), cell replication 
(fig.3A) and time-dependent replication (fig.3B). 
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The mitogenic factor stimulated DNA synthesis of 
not only rabbit aortic SMC but also rat aortic SMC 
or human skin fibroblasts, although it had most ef- 
fect on rabbit aortic SMC (table 1). This factor did 
not stimulate human umbilical vein endothelium. 
Next we characterized this factor physicochemi- 
tally and immunologically to determine its rela- 
tions with other growth factors such as PDGF. 
Table 2 summarizes the effects of various treat- 
ments on the activity of this factor. This factor was 
stable at 4°C for at least 1 month and at 56°C for 
30 min. However, two-thirds of its activity were 
lost during heat-treatment at 100°C for 10 min, 
unlike that of PDGF [l 11. Freeze-thawing did not 
reduce its activity. Its activity was increased more 
than 2-fold by incubation at pH 2.5 at 22°C for 
30 min, suggesting either the existence of an acid- 
labile inhibitor(s) of DNA synthesis in the condi- 
tioned medium or the dissociation of polymers of 
the factor during this treatment. On treatment with 
2 mM mercaptoethanol, its activity was almost 
completely lost suggesting that S-S bonds are im- 
portant for its mitogenic activity. It was not 
dialyzable through membranes with a cut-off M, of 
___ . ..l&-. 
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Fig. 1. (A) Relationship between passages of cultured SMC and secretion of mitogenic activity. Typical mitogenic activities of several 
SMC from 6 different primary cultures are shown. Each point shows the highest mitogenic activity for CM from SMC of the same 
passage. The value for [‘Hlthymidine incorporation in control cultures was adjusted to 1 and values are for thymidine incorporations 
as ratios to that of the control. (B) Time course of secretion of mitogenic activity from SMC. Typical patterns of secretion of mitogenic 
activity by three different cultures (4th-6th passage) are shown. 
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Fig.2. Dose-dependence of effect of pooled CM on DNA 
synthesis of SMC. CM from SMC at passages 4-12 from about 
20 different primary cultures, which had mitogenic activities of 
more than 3-fold that of the control, were combined and stored 
at 4°C. 
6000. In fact this dialysis slightly increased its ac- 
tivity, suggesting the presence of a low molecular 
inhibitor(s) in the conditioned medium. Its activity 
was almost completely lost on treatment with tryp- 
sin. The latter two results suggest hat the mitoge- 
nit factor is a polypeptide. Chromatography on 
Sephadex G-75 gel showed that the factor had a 
molecular mass of -8700 Da, which is different 
from those of reported growth factors, including 
PDGF and PDGF-like particles [ 1 l- 141. We nam- 
ed this factor SDGF. Details of its purification will 
be reported elsewhere. 
Secretion of PDGF-like substances from SMC 
of rats has been reported [4-71. Therefore, we 
tested whether this factor was immunologically 
similar to PDGF-like substances. As shown in 
fig.4A, polyclonal anti-PDGF antibody at 
20 pg/ml caused -80% inhibition of enhancement 
of DNA synthesis by unlabeled purified PDGF (at 
5 ng/ml). However, it did not affect DNA syn- 
thesis enhanced by 100% conditioned medium, in- 
dicating that SDGF does not cross-react 
immunologically with PDGF. To confirm this con- 
clusion, we tested the competitive inhibition by 
conditioned medium of 1251-PDGF binding to 
human skin fibroblasts. The binding of 2 ng/ml of 
12’I-PDGF to human skin fibroblasts was dose- 
dependently inhibited by unlabeled PDGF but was 
not inhibited by conditioned medium (fig.4B). 
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Fig.3. (A) Dose-dependence of effect of pooled CM on 
replication of SMC. (B) Effects of pooled CM on replication of 
SMC as a function of the incubation time. Cells were incubated 
with 30070 pooled CM until day 5. 
Thus the SDGF in the conditioned medium 
probably did not bind to the PDGF receptor. 
The above results show that SDGF differs from 
PDGF physicochemically and immunologically. 
For the following reasons SDGF also seems to dif- 
fer from other well-characterized growth factors 
such as epidermal growth factor (EGF), 
somatomedin-C, and fibroblast growth factor(s) 
(FGF), which like SDGF stimulated growth of 
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Table 1 A 
Target cell specificity of conditioned medium (CM) 
Target cells DNA synthesis of CM 
(50%) 
n-fold stimu- 
lation over 
control 
Unita 
Rabbit SMC 
Rat SMC 
Human skin fibroblasts 
Human umbilical cord 
6.5 2.60 
2.1 0.36 
1.7 0.68 
vein endothelium 0.8 - 
a 1 unit = mitogenic activity of 1% fetal bovine serum 
Rat aortic SMC were from a 3-month-old male Wistar rat. 
Human skin fibroblasts were from the foreskin of a 35yr-old 
man. Human umbilical cord vein endothelium was cultured as 
described in [18] 
B 
mesenchymal cells: the molecular mass of EGF 
[15,16] (6045 Da) is different from the tentative 
molecular mass of SDGF (8700 Da). EGF is heat- 
stable and acid-labile, whereas SDGF is heat-labile 
and acid-stable. Unlike SDGF, EGF alone did not 
stimulate DNA synthesis in cultured rabbit aortic 
SMC (not shown). No somatomedin C was 
detected by radioimmunoassay in the pooled con- 
ditioned medium. The reported molecular mass of 
FGF [17] is more than 10 kDa, which is different 
Table 2 
Effects of various treatments on the mitogenic activity of 
conditioned media 
Treatment Mitogenic 
activity (Vo) 
Fig.4. (A) Effects of anti PDGF antibody on DNA synthesis of 
SMC stimulated by pooled CM or PDGF. AntiPDGF antibody 
was added to the culture at the same time as pooled CM (100%) 
or PDGF (5 ng/ml). The dotted line shows the radioactivity in 
the absence of any growth factor. (B) Effects of pooled CM and 
unlabeled PDGF on the binding of “‘1-PDGF to human 
None 100 
Stored at 4°C for 1 month 112 
Heated at 56°C for 30 min 99 
Heated at 100°C for 10 min 35 
Freeze-thawed 95 
pH 2.5 at 22°C for 30 min 231 
Dialyzed in membranes of 3500 cut-off 153 
6000 cut-off 149 
2 mM mercaptoethanol at 22°C for 30 min 6 
0.01% trypsin at 37°C for 30 min 6 
0.1% trypsin at 37°C for 30 min 2 
Mitogenic activity was assayed by measuring [3H]thymidine 
incorporation into DNA as described in the legend to fig.lA. 
‘None’ means DNA synthesis in the presence of 100% pooled 
from the tentative molecular mass of SDGF 
(8700). FGF is acid-labile whereas SDGF is acid- 
stable. FGF stimulates DNA synthesis of human 
umbilical cord endothelium, unlike SDGF (table 
2). These indirect lines of evidence suggest that 
SDGF is a new growth factor, not previously 
reported. 
CM without any previous treatment of the latter 
The pathogenic significance of SDGF is 
unknown. Possibly SDGF is secreted in vivo by in- 
timal SMC which migrate from the aortic media 
0 2.5 5 10 20 
Anti PDGF (rglml) 
conditioned media (CM) 
PDGF 
(w/ml) 
fibroblasts (4th passage). 
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and replicate many times. Successive passages of 
the SMC in culture could mimic this in vivo pro- 
cess in atheromatous lesions. In preliminary ex- 
periments we found that cultured intimal SMC 
from atheromatous lesions of rabbit aortas induc- 
ed by the balloon-cathether method secreted a 
mitogenic factor(s) at the 2nd and 3rd passages, 
when cultured medial SMC still did not secrete 
SDGF. Thus SDGF secreted in an autocrine man- 
ner may be important for proliferation of the SMC 
in atheromatous lesions. We are now studying in- 
timal SMC. 
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